The initiation of coverage by a major financial institution like JP Morgan, especially with an Overweight rating, is a positive signal to the market. The set price target of $168, significantly higher than the current trading price, suggests a strong bullish outlook on ArcBest's future performance. This can lead to increased investor interest and potentially drive the stock price up in the short term.